Brieflist

The Life Sciences Innovative Manufacturing Fund (LSIMF)

UK registered businesses can apply for funding for life science manufacturing capital investment projects which help increase UK health resilience.

Read the official page on Find a grant ↗Start an application ↗ Get new grants like this

Funder
Department for Science, Innovation and Technology
Where
🇬🇧 United Kingdom
Status
Open, rolling
Opened
30 Oct 2024
Funding
£1m–£130m per award (£520m in total)
Who can apply
Small businesses
Topics
Health Science & research Innovation & technology

About this grant

The Life Sciences Innovative Manufacturing Fund (LSIMF) is a capital grants fund which aims to build resilience for future health emergencies and capitalise on the UK’s world-leading research and development capabilities. The fund will enhance and accelerate affordable access to mature, new and emerging Life Sciences products for both pandemic and non-pandemic scenarios.

LSIMF will provide up to £520 million in capital grants for investment in the manufacture of human medicines and medical technology (including diagnostics, and MedTech products).

This is a new fund from previous UK Government Life Sciences manufacturing funds.

LSIMF is open to all eligible companies, including previous manufacturing grant recipients, as long as the application is for a different project.

Projects with a total cost (including capital expenditure) of at least £8 million are eligible to apply.

The maximum intervention rate (ratio of grant to project costs) is 25%, with the typical intervention rate being 10-20% of your total project costs. For example, for a project with a total cost of £100m, the typical grant awarded might be £10-20m.

Objectives

Your project must align with the objectives of the fund:

To increase UK health resilience by strengthening the UK’s manufacturing capacity and capability. We define health resilience as the UK’s ability to withstand and recover from health emergencies such as pandemics, long-term healthcare challenges and supply chain disruption. For example, your project may improve health resilience by supporting or demonstrating a broad spectrum increase in domestic manufacturing capacity and capability that supports UK health resilience, and/or enhanced flexibility of manufacturing capability that can be redeployed or scaled during a health emergency.

To create economic opportunity through investments that will make a substantial contribution to Gross Value Added (GVA) and provide high-wage, high-skilled jobs around the UK.

Both of these objectives are equally weighted. Projects scoring highly against one objective may be progressed even where they score less strongly against the other – for example, a project with a strong health resilience case may be supported despite a lower economic score, and vice-versa. Nevertheless, all applications must meet a minimum threshold against each objective in order to progress.

Dates

Expressions of Interest (EOI)

EOIs require you to provide a summary of your project, which will be used to assess your project’s eligibility.

These can be submitted at any time by clicking the button above. However, EOIs must be submitted by the below deadlines in order to be considered as part of that application round. EOIs submitted after the deadline will be considered as part of the subsequently quarterly round.

⁠Round 8 will close on 14 August 2026 at 12PM.

⁠Round 9 will close on 13 November 2026 at 12PM.

Subsequent rounds will open on a quarterly basis until all the funding has been allocated.

To ensure the fund meets its objectives and adapts to market activity, the scheme will undergo an annual review, therefore the criteria and application windows are subject to change. This page will be updated regularly with details on future application rounds.

If your project EOI is deemed eligible you will be invited to submit a formal application.

Eligibility

Your company

To be eligible to apply for the fund, your company must be:

A UK registered company, or a UK registered establishment

UK establishments must also have at least one UK registered company in their group structure

A wholly private sector business

A product developer, contract development manufacturing organisation, or a generics manufacturer.

Applicants must also be able to provide two years of audited accounts for the applicant company (and/or if applicable, parent entity). If this is not available – for example because the company is not required by Companies House to submit audited accounts – we will ask for demonstration that the remaining funding required for the project to go ahead is available. You may be also asked for evidence that your company (or if applicable, parent entity) has a track record of successfully manufacturing medicines or medical devices in the UK or abroad, or that you have successfully developed a product intended for commercial scale-up.

Your project

To be eligible for the fund, your project must:

Have a total eligible cost of at least £8 million. Eligible costs include capital, R&D and skills/training expenditure. This should exclude operational expenditure.

Be located in the UK

Be primarily a capital investment

Be a single company investment, or a joint investment between multiple entities within the same company group structure (as opposed to forming a partnership between independent companies or other types of organisations)

Require only the amount of grant requested to proceed. For example, without the specific amount of funding you are requesting your project wouldn’t go ahead or go ahead at a smaller scale, go ahead overseas or would be significantly delayed (3 years or more)

Your project must be a manufacturing project for the manufacture of:

Human medicines (this includes both the manufacture of active pharmaceutical ingredients (API) / drug substance and finished product / drug product)

Medical diagnostics – for both disease identification and monitoring

MedTech products – all types of medical devices related to human health.

The fund is open to applications for MHRA-licenced medicines, medical and diagnostic devices registered with the MHRA, and products in development where approval to market or manufacture the medicine or device in the UK is intended to be sought for commercial scale-up, for example a manufacturing project for clinical trials or investigational studies.

Manufacturing …

Applying for grants? Grants Pro e-mails you every morning with the new grants and opened forecasts that match your saved searches, and adds deadline reminders in your calendar, a private RSS feed and CSV export. Try it free for 7 days, then $9/month, cancel any time. See what Pro does →

Applying? Read how to write a winning grant proposal.

Contains public sector information licensed under the Open Government Licence v3.0 (Find a grant). Last checked 19 Nov 2026. Always read the official page before applying: it has the full conditions, documents and how to apply.

Similar grants

Gambling harms research grants (Grant)

UK Research and Innovation, Arts and Humanities Research Council, Medical Research Council, Economic and Social Research Council, Biotechnology and Biological Sciences Research Council · UK · £1–£2m

Closes 8 Dec 2026 · 18 days left Most organisations

Condition Improvement Fund (CIF)

Department for Education · UK · £20k–£4m

Closes 15 Dec 2026 · 25 days left Nonprofits & charities Universities & schools Public bodies